Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph M Foster

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
BMC Medical Genomics|March 20, 2017
Comparing mutation calls in fixed tumour samples between the affymetrix OncoScan® array and PCR based next-generation sequencingHenry M Wood, Joseph M Foster, Morag Taylor, et al.
Nature Biotechnology|February 10, 2012
PRIDE Inspector: a tool to visualize and validate MS proteomics dataRui Wang, Antonio Fabregat, Daniel Ríos, et al.
Nucleic Acids Research|December 4, 2012
The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013Juan Antonio Vizcaíno, Richard G Côté, Attila Csordas, et al.
The Journal of Pathology|December 23, 2015
HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trialsSusan D Richman, Katie Southward, Philip Chambers, et al.
BMC Medical Genomics|April 19, 2015
Cross-laboratory validation of the OncoScan® FFPE Assay, a multiplex tool for whole genome tumour profilingJoseph M Foster, Assa Oumie, Fiona S Togneri, et al.
European Journal of Human Genetics : EJHG|January 14, 2016
Genomic complexity of urothelial bladder cancer revealed in urinary cfDNAFiona S Togneri, Douglas G Ward, Joseph M Foster, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
BMC Medical Genomics|March 20, 2017
Comparing mutation calls in fixed tumour samples between the affymetrix OncoScan® array and PCR based next-generation sequencingHenry M Wood, Joseph M Foster, Morag Taylor, et al.
Nature Biotechnology|February 10, 2012
PRIDE Inspector: a tool to visualize and validate MS proteomics dataRui Wang, Antonio Fabregat, Daniel Ríos, et al.
Nucleic Acids Research|December 4, 2012
The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013Juan Antonio Vizcaíno, Richard G Côté, Attila Csordas, et al.
The Journal of Pathology|December 23, 2015
HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trialsSusan D Richman, Katie Southward, Philip Chambers, et al.
BMC Medical Genomics|April 19, 2015
Cross-laboratory validation of the OncoScan® FFPE Assay, a multiplex tool for whole genome tumour profilingJoseph M Foster, Assa Oumie, Fiona S Togneri, et al.
European Journal of Human Genetics : EJHG|January 14, 2016
Genomic complexity of urothelial bladder cancer revealed in urinary cfDNAFiona S Togneri, Douglas G Ward, Joseph M Foster, et al.
Pageof 2